OS Therapies:与英国MHRA安排的Ost-Her2预上市许可申请会议定于12月8日举行
OS Therapies:与英国MHRA安排的Ost-Her2预上市许可申请会议定于12月8日举行
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.